A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity-Reference-Cited by-同舟云学术

A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity

Published:2014-02-24 Issue:2 Volume:9 Page:e88846
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Maeyama Jun-ichi,Takatsuka Hisakazu,Suzuki Fumiko,Kubota Ayumi,Horiguchi Satomi,Komiya Takako,Shimada Ichiroh,Murata Eri,Osawa Youko,Kitagawa Harukazu,Matsuki Takasumi,Isaka Masanori,Yamamoto Saburo,Iho Sumiko

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. The mucosal immune system: from fundamental concepts to vaccine development;JR McGhee;Vaccine,1992

2. Mucosal immunity and vaccines;J Holmgren;Nat Med,2005

3. Mucosal vaccines: the promise and the challenge;MR Neutra;Nat Rev Immunol,2006

4. Therapeutic potential of Toll-like receptor 9 activation;AM Krieg;Nat Rev Drug Discov,2006

5. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists;J Vollmer;Adv Drug Deliv Rev,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality;Viruses;2024-03-08

2. Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments;Vaccine;2023-02

3. Expression of Concern: A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity;PLOS ONE;2023-01-11

4. The Nucleocapsid Protein Of SARS-CoV-2, Combined With ODN-39M, Is A Potential Component For An Intranasal Bivalent Pancorona Vaccine;2022-06-02

5. Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening;Advanced Materials;2022-01-31